New Stock Coverage: Noodles & Co Looks a Little Limp

Shutterstock photo

Equities wore a crown of thorns as President Obama, who never promised us a rose garden (even in the Rose Garden ) and Congress continued to be at odds and Roseland, New Jersey-based ADP announced decidedly iffy private payroll growth. Both the Commander in Chief, always inordinately fond of the first-person pronoun , and Capitol Hill were politely reminded by the American people that there is no "I" in Team ( TISI ). (Just as well, on a day that stock nosedived an NYSE-worst 13.87%.) While Wall Street didn't do so well, with the Dow (INDEXDJX:.DJI) dropping for an eighth time in 10, there were triple miracles on 34th Street. The Empire State ( ESRT ) Building owner bucked a bad tape to increase 0.77% after its IPO, Macy's ( M ) jumped 1.22% - even if its slave-driver bosses are total turkeys - and Madison Square Garden ( MSG ) - better than any rose garden - gained 0.17% after being anointed the country's coolest arena .

Today in economics, analysts expect to see a slippage in September's Institute for Supply Management services index at 10:00 a.m. Eastern. On the corporate earnings front, Comtech Telecommunications ( CMTL ), Constellation Brands (STZ), International Speedway (ISCA), and Xyratex (XRTX) are all due to release results.

Angie's List (ANGI): Shares, slumping before the bell after cutting certain membership prices by about 75%, are nonetheless initiated with a Buy at MKM Partners.

Arena Pharmaceuticals (ARNA): Cowen establishes a Market Perform rating and $4.50 price target on ARNA.

Coach (COH): COH is covered with a Buy opinion and $66 price objective at Cantor Fitzgerald, which is impressed with its sales momentum.

ExamWorks (EXAM): Needham assigns a Buy recommendation on EXAM, citing stable costs and increased market share. Its price objective is $31.

LivePerson (LPSN): Janney has a new Neutral on the business services name.

Mast Therapeutics (MSTX): Canaccord Genuity begins the biotech microcap, up impressively before the bell, with a Buy rating and $3 price target.

Murphy Oil (MUR): The energy outfit is a new Neutral at Credit Suisse, whose target price is $70.

Noodles & Co (NDLS): Shares are begun with an uninspiring Equal Weight rating at Barclays. Its objective is $39.

NPS Pharmaceuticals (NPSP): NPSP is a new Buy at Bank of America-Merrill Lynch.

Regions Financial (RF): Wunderlich resumes Buy-rated research and a $12 target on RF, highlighting the substantial discount its shares trade at relative to industry rivals.

TC Pipelines (TCP): RBC Capital launches Sector Perform rated coverage of the limited partnership. Its price objective is $51.

Tiffany & Co (TIF): Market share increases sees the upscale jeweler score a Buy initiation and $88 objective at Cantor.

Yara (OTCMKTS:YARIY): Barclays has a fresh Equal Weight on the fertilizer firm.

(See also: Stock Upgrades: Vivus Stock Is to Diet For and Stock Downgrades: Fair-Weather 'Friends' Flee Facebook .)

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Stocks
Referenced Symbols: CMTL , ESRT , M , MSG , TISI

More from Minyanville




Research Brokers before you trade

Want to trade FX?

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by